14Nerve If You Can, Nucleus If You Must: ABI versus CI

FTwo implants, two very different starting points

A cochlear implant and an auditory brainstem implant share the same goal, restoring electric hearing, and even similar processors, yet they begin at opposite ends of the auditory pathway. The CI sits inside the cochlea and stimulates the spiral ganglion and cochlear nerve, the body’s own first relay of sound. The ABI sits on the surface of the cochlear nucleus in the brainstem, one synapse further upstream, used only when the nerve itself is gone or unusable.

That single anatomical difference explains almost everything that follows. The CI hands its signal to a structure exquisitely organised for hearing; the ABI must paint onto the outside of a nucleus whose finely tuned cell layers are buried beneath the surface and intermixed with non-auditory neurons. Same engineering philosophy, profoundly different biological canvas.[2024][2006]

TWhy the cochlear nerve is irreplaceable

The cochlea and its nerve perform encoding that no surface array can reproduce. Tens of thousands of nerve fibres are laid out in a precise tonotopic order, each tuned to a narrow frequency, with timing locked to the fine structure of sound. A cochlear implant taps into this ready-made place map: each electrode addresses a distinct, predictable region, so spectral channels stay separate and speech information is preserved.

The cochlear nucleus does contain a tonotopic organisation too, but its frequency layers run obliquely and lie below the surface, so a sheet of surface electrodes reaches an overlapping, partly non-auditory population. Pitches from neighbouring contacts blur together, side effects from spread to other cranial-nerve nuclei are common, and the rich temporal-place code the cochlea delivers for free has to be approximated crudely. This is the core reason ABI speech scores trail CI scores so widely.[2008][2024]

CDrawing the candidacy boundary

The decision tree turns on one question: is there a functioning cochlear nerve? If imaging shows a cochlear nerve and the cochlea can be reached, the cochlear implant is the answer, even for very abnormal ears, because it will almost always outperform an ABI. The ABI is reserved for the situations where a CI cannot work: NF2 with the nerve sacrificed during tumour removal, cochlear nerve aplasia or severe deficiency, bilateral nerve avulsion from trauma, and cochleae so ossified or malformed that no electrode can be placed.

Two grey zones deserve care. In cochlear nerve deficiency a thin nerve may still carry an electrically evoked response, so a CI trial can be justified before defaulting to an ABI. And in NF2 a CI is worth attempting if the nerve was anatomically preserved during tumour removal, since even a preserved nerve beats the nucleus. The watchword is to prove the nerve cannot serve before bypassing it.[2024][2024][2006]

CThe governing principle: implant the nerve if you can

Boiled down, the comparison gives a clinical maxim: implant the nerve if you can, the nucleus only if you must. The cochlear implant should be the default for any deaf ear with a usable cochlear nerve, and the brainstem implant the considered fallback when that nerve is absent or destroyed. Choosing an ABI when a CI was possible trades the cochlea’s superb peripheral encoding for a far coarser interface and a markedly lower expected outcome.

This principle also shapes how the two devices are sometimes combined. A child with bilateral cochlear nerve deficiency may receive a CI on the better side and an ABI on the other, letting each pathway contribute what it can. But even there the logic is unchanged: the nerve is preferred wherever it exists, and the nucleus fills the gap it leaves behind.[2020][2024]